<DOC>
	<DOC>NCT01033396</DOC>
	<brief_summary>PF-03654764 should reduce the symptoms of allergic rhinitis. In this study patients will be exposed to pollen and their symptoms observed.</brief_summary>
	<brief_title>The Effect Of PF-03654764 +/- Allegra On Symptoms Of Allergic Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Fexofenadine</mesh_term>
	<mesh_term>Terfenadine</mesh_term>
	<criteria>Male or female subjects 1860 years allergic to ragweed pollen. Subjects with appropriate symptom scores following exposure to ragweed in the environmental exposure unit. Subjects with significant diseases other than allergic rhinitis that may interfere with the safety or efficacy of PF03654764. Subjects with significant symptoms of allergic rhinitis within the 2 weeks prior to screening.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Allergic rhinitis Environmental exposure unit</keyword>
</DOC>